[1]
“Remarkable and Prolonged Response to Melphalan and High-Dose Dexamethasone Combined Therapy of a Patient with Light-Chain Cardiac Amyloidosis”, Biomed. Res. Ther., vol. 10, no. 11, pp. 6049–6056, Nov. 2023, doi: 10.15419/bmrat.v10i11.846.